ERBB2 and invasive breast carcinoma: TIL are usually associated with HER2‐positive and TN subtypes rather than luminal subtype of invasive breast cancers 15, and the clinical value of TIL (anti‐ and pro‐tumoral) could be subtype dependent 16.